2004
231. Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: an in vitro evaluation.
Anton M, Wittermann C, Haubner R, Simoes M, Reder S, Essien B, Wagner B, Henke J, Erhardt W, Noll S, Hackett NR, Crystal RG, Schwaiger M, Gansbacher B, Bengel FM
J Nucl Med. 2004 Oct .
233. Inducible nonviral gene expression in the treatment of osteochondral defects.
Ueblacker P, Wagner B, Krüger A, Vogt S, DeSantis G, Kennerknecht E, Brill T, Hillemanns M, Salzmann GM, Imhoff AB, Plank C, Gänsbacher B, Martinek V
Osteoarthritis Cartilage. 2004 Sep .
234. Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents.
Schweinitz A, Steinmetzer T, Banke IJ, Arlt MJ, Stürzebecher A, Schuster O, Geissler A, Giersiefen H, Zeslawska E, Jacob U, Krüger A, Stürzebecher J
J Biol Chem. 2004 Aug 6.
235. Gene delivery to respiratory epithelial cells by magnetofection.
Gersting SW, Schillinger U, Lausier J, Nicklaus P, Rudolph C, Plank C, Reinhardt D, Rosenecker J
J Gene Med. 2004 Aug .
238. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.
Anton M, Wagner B, Haubner R, Bodenstein C, Essien BE, Bönisch H, Schwaiger M, Gansbacher B, Weber WA
J Gene Med. 2004 Jan .
240. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M, Voelcker V, Köllisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M
J Invest Dermatol. 2003 Dec .
